GB1396206A - Prostaglandins and the preparation thereof - Google Patents

Prostaglandins and the preparation thereof

Info

Publication number
GB1396206A
GB1396206A GB1542473A GB1542473A GB1396206A GB 1396206 A GB1396206 A GB 1396206A GB 1542473 A GB1542473 A GB 1542473A GB 1542473 A GB1542473 A GB 1542473A GB 1396206 A GB1396206 A GB 1396206A
Authority
GB
United Kingdom
Prior art keywords
analogues
pge
pgf
prostaglandins
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1542473A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of GB1396206A publication Critical patent/GB1396206A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB1542473A 1972-04-27 1973-03-30 Prostaglandins and the preparation thereof Expired GB1396206A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24801372A 1972-04-27 1972-04-27

Publications (1)

Publication Number Publication Date
GB1396206A true GB1396206A (en) 1975-06-04

Family

ID=22937288

Family Applications (2)

Application Number Title Priority Date Filing Date
GB1542473A Expired GB1396206A (en) 1972-04-27 1973-03-30 Prostaglandins and the preparation thereof
GB3200874A Expired GB1396207A (en) 1972-04-27 1973-03-30 Prostaglandin intermediates and the preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB3200874A Expired GB1396207A (en) 1972-04-27 1973-03-30 Prostaglandin intermediates and the preparation thereof

Country Status (8)

Country Link
JP (2) JPS5939426B2 (ja)
BE (1) BE798829A (ja)
CH (1) CH585198A5 (ja)
FR (1) FR2183041B1 (ja)
GB (2) GB1396206A (ja)
HU (1) HU168570B (ja)
NL (1) NL7305817A (ja)
ZA (1) ZA732244B (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2146325A (en) * 1983-09-07 1985-04-17 Erba Farmitalia 16-Fluoro-16,17-didehydro prostanoids and process for their preparation
WO2002094274A1 (en) * 2001-05-18 2002-11-28 Sucampo Ag Cathartic composition
CN110218776A (zh) * 2019-06-14 2019-09-10 苏州叠代生物科技有限公司 Pcr油相组合物及其制备方法

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4052446A (en) * 1973-08-06 1977-10-04 Hoffmann-La Roche Inc. 11,16-substituted prostaglandins
US4017534A (en) * 1974-06-03 1977-04-12 American Cyanamid Company 16-Fluoro-11-deoxy-13-dihydro-prostaglandin
JPS52145350A (en) * 1976-05-31 1977-12-03 Hitachi Ltd Complete fillet welding of tee joint having vvshaped groove
JPS5524138A (en) * 1978-08-11 1980-02-21 Toray Ind Inc Optically active synthetic intermediate and its preparation
JPS6072860A (ja) * 1983-09-07 1985-04-24 インデイアナ ユニバーシテイ フアウンデーシヨン 12,16‐ジフルオロプロスタグランジンf↓2‖化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL32552A (en) * 1968-07-29 1975-07-28 Upjohn Co Prostaglandin analogs
BR6915068D0 (pt) * 1969-03-14 1973-05-24 Upjohn Co Processo de producao de derivados racemicos de prostaglandina

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2146325A (en) * 1983-09-07 1985-04-17 Erba Farmitalia 16-Fluoro-16,17-didehydro prostanoids and process for their preparation
WO2002094274A1 (en) * 2001-05-18 2002-11-28 Sucampo Ag Cathartic composition
US6956056B2 (en) 2001-05-18 2005-10-18 Sucampo Ag Method for providing a cathartic effect
AU2002307725B2 (en) * 2001-05-18 2008-07-10 Sucampo Ag Cathartic composition
US7459583B2 (en) 2001-05-18 2008-12-02 Sucampo Ag Method for providing a cathartic effect
CN110218776A (zh) * 2019-06-14 2019-09-10 苏州叠代生物科技有限公司 Pcr油相组合物及其制备方法

Also Published As

Publication number Publication date
JPS5993070A (ja) 1984-05-29
HU168570B (ja) 1976-05-28
FR2183041A1 (ja) 1973-12-14
ZA732244B (en) 1974-03-27
GB1396207A (en) 1975-06-04
JPS5939426B2 (ja) 1984-09-22
JPS4914458A (ja) 1974-02-07
JPS5938235B2 (ja) 1984-09-14
CH585198A5 (ja) 1977-02-28
BE798829A (fr) 1973-10-29
FR2183041B1 (ja) 1977-11-10
NL7305817A (ja) 1973-10-30

Similar Documents

Publication Publication Date Title
GB1515414A (en) 2 descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanorprostaglandins
US4127726A (en) Cis-13-PGE2, 15 methyl ethers
US4097508A (en) Cis-4,5-didehydro-13,14 dihydro-9, dioxy PGF compounds
IE38241B1 (en) Prostanoic acid derivatives
GB1396206A (en) Prostaglandins and the preparation thereof
GB1506824A (en) Prostaglandins
GB1386146A (en) Cyclopentane derivatives
GB1497218A (en) Thiaprostaglandins
GB1506817A (en) Prostaglandins
US4065628A (en) 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGE, compounds
US4001286A (en) Phenyl-substituted prostaglandin-β-type anologs
US4115651A (en) CIS-4,5-Didehydro-13,14-didehydro-11-deoxy-17-phenyl-18,19,20-trinor-PGF.sub.1α compounds
GB1434620A (en) Prostaglandins and the preparation thereof
GB1508168A (en) 11-deoxy-15-substituted-16,17,18,19,20-pentanorprostaglandins
US4206311A (en) 2-Decarboxy-2-hydroxy-methyl-13,14-didehydro-17-phenyl PGF compounds
GB1398346A (en) Prostaglandins and the preparation thereof
GB1398291A (en) Prostaglandin analogues and production thereof
GB1456511A (en) P-biphenylyl esters of 15-substituted-16,17,18,19,20-pentanor prostaglandins
GB1462716A (en) Prosta-5-cis,11,13-trnas-trienoic acids and derivatives thereof
IE43821L (en) Prostaglandins
GB1436831A (en) Prostaglandins and the preparation thereof
GB1460519A (en) Polyunsaturated prostaglandin derivatives and process
US4005115A (en) Phenyl-substituted prostaglandin-A type analogs
GB1445628A (en) Prostaglandin derivatives
US4207422A (en) 2-Decarboxy-2-hydroxymethyl-3,7-inter-m-phenylene-13,14-didehydro-PGA, PGD, and PGE compounds

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee